All Stories

  1. The Gut Microbiota–Sex–Immunity Axis in Non-Communicable Diseases
  2. Inflammasomes in Cardiovascular Diseases: Current Knowledge and Future Perspectives
  3. Sex Differences in Cardiovascular Diseases: Exploring the Role of Microbiota and Immunity
  4. Advances in COVID-19 and Cancer Research
  5. Gut–Kidney–Heart: A Novel Trilogy
  6. The role of SARS-COV-2 infection in promoting abnormal immune response and sepsis: A comparison between SARS-COV-2-related sepsis and sepsis from other causes
  7. Effect of COVID-19 Vaccination on the In-Hospital Prognosis of Patients Admitted during Delta and Omicron Waves in Italy
  8. Current Evidence on Vaccinations in Pediatric and Adult Patients with Systemic Autoinflammatory Diseases
  9. Delirium in Head Trauma: Looking for a Culprit
  10. Risk Factors Associated with Post-Operative Complications in Multidisciplinary Treatment of Descending Necrotizing Mediastinitis
  11. The Role of Gut Microbiota in Heart Failure: When Friends Become Enemies
  12. Use of POCUS in Chest Pain and Dyspnea in Emergency Department: What Role Could It Have?
  13. Gut Microbiota and Chronic Diseases and Conditions
  14. The Crosstalk between Gut Microbiota, Intestinal Immunological Niche and Visceral Adipose Tissue as a New Model for the Pathogenesis of Metabolic and Inflammatory Diseases: The Paradigm of Type 2 Diabetes Mellitus
  15. Recent Advances in Vaccine Technology and Design
  16. Vaccines, Microbiota and Immunonutrition: Food for Thought
  17. Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy
  18. Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization
  19. Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study
  20. Characteristics of patients with cancer in European long-term care facilities
  21. Microbiota and Myopericarditis: The New Frontier in the Car-Diological Field to Prevent or Treat Inflammatory Cardiomyo-Pathies in COVID-19 Outbreak
  22. Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey
  23. Microbiota and Probiotics: The Role of Limosilactobacillus Reuteri in Diverticulitis
  24. Pollution, Inflammation, and Vaccines: A Complex Crosstalk
  25. Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases
  26. Gut Microbiota and Acute Diverticulitis: Role of Probiotics in Management of This Delicate Pathophysiological Balance
  27. Luteolin, inflammation and cancer: Special emphasis on gut microbiota
  28. Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World
  29. Angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID‐19
  30. The Interplay between Immunosenescence and Microbiota in the Efficacy of Vaccines
  31. COVID-19 and intestinal inflammation: Role of fecal calprotectin
  32. Physical performance measures and hospital outcomes among Italian older adults: results from the CRIME project
  33. Assessment of neurological manifestations in hospitalized patients with COVID‐19
  34. Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID‐19
  35. Interleukin-6 in Rheumatoid Arthritis
  36. Anticoagulant therapy in the treatment of splanchnic vein thrombosis associated to acute pancreatitis: a 3-year single-centre experience
  37. Risk factors for bloodstream infections in gynecological cancer
  38. Rationale for ozone-therapy as an adjuvant therapy in COVID-19: a narrative review
  39. Precision editing of the gut microbiota ameliorates cancer immunotherapy.
  40. Early oral vs parenteral nutrition in acute pancreatitis: a retrospective analysis of clinical outcomes and hospital costs from a tertiary care referral center
  41. Interrelationship between inflammatory cytokines (IL-1, IL-6, IL-33, IL-37) and acquired immunity.
  42. The Importance of Complying with Vaccination Protocols in Developed Countries: “Anti-Vax” Hysteria and the Spread of Severe Preventable Diseases
  43. The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer
  44. An update in breast cancer management for elderly patients
  45. Integrins: Integrating the Biology and Therapy of Cell–cell Interactions
  46. Immune Modulation by Vitamin D: Special Emphasis on Its Role in Prevention and Treatment of Cancer